SCANDINAVIAN BIOPHARMA HOLDING AB
SOLNA, STOCKHOLM 171 48
$30.88M
Total Contract Value
7 awards
First Award
May 5, 2022
Last Award
May 29, 2025
Business Size
other than small
CAGE Code
AYBAN
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $30.88M | 7 |
Contract Awards
6 awards found
W81XWH20C0137
Department of Defense
$46K
May 29, 2025
CONTRACT FOR DIARRHEA PREVENTION FOR TACTICAL ENVIRONMENTS TESTING AND MANUFACTURE.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
W81XWH20C0137
Department of Defense
$606K
Mar 10, 2025
THIS REQUIREMENT IS FOR THE RESEARCH AND PRODUCTION OF AN ENTEROTOXIGENIC E. COLI VACCINE TO HELP REDUCE WARFIGHTER DOWN TIME WHEN SERVING IN THEATRE.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
W81XWH20C0137
Department of Defense
$20.48M
Sep 18, 2024
THIS CONTRACT IS FOR THE DEVELOPMENT OF AN E. COLI VACCINE FOR FDA APPROVAL.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
W81XWH20C0137
Department of Defense
$254K
Aug 29, 2023
ENTEROTOXIGENIC E. COLI VACCINE DEVELOPMENT.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
W81XWH20C0137
Department of Defense
$5.19M
Apr 5, 2023
E. COLI VACCINE DEVELOPMENT.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
W81XWH20C0137
Department of Defense
$4.31M
May 5, 2022
FURTHER DEVELOPMENT OF ETVAX, A VACCINE AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC).
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022
Business Details
- UEI
- ZKASUJ7ZZC98
- CAGE Code
- AYBAN
- Address
- INDUSTRIVAGEN 1, 4TR
SOLNA, 171 48
Parent Company
SCANDINAVIAN BIOPHARMA HOLDING AB
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov